Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
To compare the efficacy in terms of the pathological complete response rate (pCR) to preoperative administration of qw or q3w Paclitaxel, Carboplatin and Trastuzumab (PCH)
Epistemonikos ID: 9e48b85b705e56513a64ea5134d5192c71077403
First added on: May 05, 2024